» Articles » PMID: 18513521

Predicting Major Adverse Cardiac Events After Percutaneous Coronary Intervention: the Texas Heart Institute Risk Score

Overview
Journal Am Heart J
Date 2008 Jun 3
PMID 18513521
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many models have been devised in the past to predict adverse outcomes after PCI, but with rapid advancements in this field, a new risk-prediction model may be needed. The purpose of our study was to identify the clinical and angiographic variables associated with adverse cardiac events after percutaneous coronary intervention (PCI) and to construct a simple bedside tool for risk stratification of PCI patients.

Methods: Using our institution's database, we analyzed data from 9,494 patients who underwent PCI between January 1, 1996, and December 31, 2002 (ie, during the bare-metal stent era). Predictors of major adverse cardiac events--death, myocardial infarction, stroke, and repeat revascularization by emergent coronary artery bypass grafting or PCI--were identified by multivariate logistic regression analysis using baseline clinical, angiographic, and procedural variables. A simple integer score was constructed by multiplying the beta coefficient for each variable by a constant and rounding the result to the nearest integer. The score was validated in 5,545 patients who underwent PCI between January 1, 2003, and December 31, 2006 (ie, during the drug-eluting stent era).

Results: Multivariate regression analysis identified emergent procedure, urgent procedure, unstable angina, acute myocardial infarction, renal insufficiency, hypertension, congestive heart failure, peripheral vascular disease, type C lesion, presence of thrombus, and number of stents placed as independent predictors of adverse events after PCI. The model had good overall discrimination (area under the receiver operator characteristic curve 0.701), and the model fitted the validation cohort adequately.

Conclusions: Risk of complications after PCI can be assessed with this simple tool, which may permit comparisons between different operators as well as different hospitals.

Citing Articles

Impact of complete versus culprit-only revascularization on major adverse cardiovascular event in diverse subpopulations.

Ansari H, Dar F, Shaikh N, Noman A, Ahmed K, Asad U Future Cardiol. 2024; 20(11-12):627-637.

PMID: 39230509 PMC: 11520548. DOI: 10.1080/14796678.2024.2387516.


Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study).

Duracinsky M, Yaya I, Yombo-Kokule L, Bessonneau P, Thonon F, Rousset-Torrente O BMJ Open. 2024; 14(6):e075315.

PMID: 38839381 PMC: 11163614. DOI: 10.1136/bmjopen-2023-075315.


The Burden of Short-term Major Adverse Cardiac Events and its Determinants after Emergency Percutaneous Coronary Revascularization: A Prospective Follow-up Study.

Kumar R, Shah J, Solangi B, Ammar A, Kumar M, Khan N J Saudi Heart Assoc. 2022; 34(2):100-109.

PMID: 36237223 PMC: 9518725. DOI: 10.37616/2212-5043.1302.


Comparison of SYNTAX score strata effects of percutaneous and surgical revascularization trials: A meta-analysis.

Gaudino M, Hameed I, Di Franco A, Naik A, Demetres M, Biondi-Zoccai G J Thorac Cardiovasc Surg. 2021; 165(4):1405-1413.e13.

PMID: 34176619 PMC: 8805094. DOI: 10.1016/j.jtcvs.2021.05.036.


Current Concepts in the Clinical Utility of Platelet Reactivity Testing.

Collet J Interv Cardiol. 2018; 8(2):100-106.

PMID: 29588760 PMC: 5808737. DOI: 10.15420/icr.2013.8.2.100.